These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 8835061)

  • 21. The efficacy of oral ondansetron and dexamethasone for the prevention of acute chemotherapy-induced nausea and vomiting associated with moderately emetogenic chemotherapy - a retrospective audit.
    Ng WL; Della-Fiorentina SA
    Eur J Cancer Care (Engl); 2010 May; 19(3):403-7. PubMed ID: 19686353
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Scopolamine for cancer-related nausea and vomiting.
    LeGrand SB; Walsh D
    J Pain Symptom Manage; 2010 Jul; 40(1):136-41. PubMed ID: 20619216
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Clinical efficacy of GG032X tablets, a new dosage form of ondansetron (fast dispersing tablet), on cisplatin-induced nausea and emesis].
    Ariyoshi Y; Nukariya N; Akasaka Y; Suminaga M; Ota J; Ikeda M; Taguchi T
    Gan To Kagaku Ryoho; 1997 Jun; 24(8):995-1011. PubMed ID: 9212810
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Extrapyramidal reaction caused by ondansetron.
    Krstenansky PM; Petree J; Long G
    Ann Pharmacother; 1994 Feb; 28(2):280. PubMed ID: 8173151
    [No Abstract]   [Full Text] [Related]  

  • 25. Managing an extrapyramidal reaction caused by ondansetron.
    Camp-Sorrell D
    Oncol Nurs Forum; 1995 May; 22(4):718-9. PubMed ID: 7675679
    [No Abstract]   [Full Text] [Related]  

  • 26. Antiemetic therapy for nausea and vomiting in the emergency department.
    Patanwala AE; Amini R; Hays DP; Rosen P
    J Emerg Med; 2010 Sep; 39(3):330-6. PubMed ID: 20022195
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Haloperidol versus ondansetron for prophylaxis of postoperative nausea and vomiting.
    Rosow CE; Haspel KL; Smith SE; Grecu L; Bittner EA
    Anesth Analg; 2008 May; 106(5):1407-9, table of contents. PubMed ID: 18420852
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prospective evaluation of ondansetron for undifferentiated nausea and vomiting in the prehospital setting.
    Warden CR; Moreno R; Daya M
    Prehosp Emerg Care; 2008; 12(1):87-91. PubMed ID: 18189184
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nurses' perceptions of antiemetic effectiveness.
    Rhodes VA; McDaniel RW; Simms SG; Johnson M
    Oncol Nurs Forum; 1995 Sep; 22(8):1243-52. PubMed ID: 8532549
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dexamathasone and ondansetron in paediatric tonsillectomy.
    Falzon D; Jefferson P; Ball DR
    Anaesthesia; 2012 Feb; 67(2):191-2. PubMed ID: 22251119
    [No Abstract]   [Full Text] [Related]  

  • 31. Pharmacist development and use of antiemetic protocols.
    Favier M; de Cazanove F; Bressolle F; Bons F; Coste E; Galtier M
    Am J Health Syst Pharm; 1995 Feb; 52(3):319-20. PubMed ID: 7749962
    [No Abstract]   [Full Text] [Related]  

  • 32. Migraine-type headaches in children receiving chemotherapy and ondansetron.
    Khan RB
    J Child Neurol; 2002 Nov; 17(11):857-8. PubMed ID: 12585731
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ondansetron is safe and effective for prehospital treatment of nausea and vomiting by paramedics.
    Salvucci AA; Squire B; Burdick M; Luoto M; Brazzel D; Vaezazizi R
    Prehosp Emerg Care; 2011; 15(1):34-8. PubMed ID: 21091329
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Anaphylactic reaction to ondansetron.
    Weiss KS
    Arch Intern Med; 2001 Oct; 161(18):2263. PubMed ID: 11575988
    [No Abstract]   [Full Text] [Related]  

  • 35. In brief: intravenous ondanstron (Zofran) 32 mg withdrawn.
    Med Lett Drugs Ther; 2012 Dec; 54(1406):104. PubMed ID: 23282793
    [No Abstract]   [Full Text] [Related]  

  • 36. Ondansetron-induced migraine-type headache.
    Singh V; Sinha A; Prakash N
    Can J Anaesth; 2010 Sep; 57(9):872-3. PubMed ID: 20661681
    [No Abstract]   [Full Text] [Related]  

  • 37. Anaphylactic reaction owing to ondansetron administration in a child with neuroblastoma and safe use of granisetron: a case report.
    Demir HA; Batu ED; Yalçın B; Civelek E; Saçkesen C; Büyükpamukçu M
    J Pediatr Hematol Oncol; 2010 Nov; 32(8):e341-2. PubMed ID: 20921907
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Odansetron.
    Betcher DL; Burnham N
    J Pediatr Oncol Nurs; 1991 Oct; 8(4):183-5. PubMed ID: 1834086
    [No Abstract]   [Full Text] [Related]  

  • 39. Unusual reactions to 5-HT3 receptor antagonists in a child with rhabdomyosarcoma.
    Lee CY; Ratnapalan S; Thompson M; Nathan PC; Closs J; French A; Punnett A; Garcia-Bournissen F; Ito S; Koren G
    Can J Clin Pharmacol; 2010; 17(1):e1-4. PubMed ID: 20051608
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ramosetron versus ondansetron in the prevention of chemotherapy-induced gastrointestinal side effects: A prospective randomized controlled study.
    Shi Y; He X; Yang S; Ai B; Zhang C; Huang D; Dong M; Liu P; Zhou S; Han X
    Chemotherapy; 2007; 53(1):44-50. PubMed ID: 17202811
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.